Infection with Helicobacter pylori is a major risk factor for chronic atrophic gastritis (CAG), a precursor lesion of intestinal gastric cancer. The pathogenicity of the bacterium is thought to play an important role in determining the extent and severity of clinical outcome. We aimed to assess the associations between CAG and the serostatus of antibodies to 15 H. pylori proteins. The analyses were based on 534 cases with serologically defined CAG and 1,068 age-matched and sex-matched controls participating in a population-based study conducted in Saarland, Germany among 9,953 men and women ages 50 to 74 years. A newly developed H. pylori multiplex serology method was used to detect antibodies specific to 15 H. pylori antigens. Significant associations were observed between seropositivity for all 15 specific antibodies and the presence of CAG. Exclusion of severe cases, who might have lost the infection in the course of CAG progression, substantially increased the observed associations. In H. pylori-seropositive subjects, cytotoxin-associated gene A (CagA), vacuolating toxin (VacA), helicobacter cysteine-rich protein C (HcpC), and the chaperonin GroEL were identified as independent virulence factors for CAG with adjusted odds ratios (95% confidence interval) of 3.52 (2.01-6.10), 3.19 (1.44-7.05), 4.03 (1.53-10.65), and 2.65 (1.06-6.62), respectively; the simultaneous presence of all four independent virulence factors was associated with an 18-fold risk of CAG. In conclusion, HcpC and GroEL were identified as new independent virulence factors, and in combination with the established virulence factors, CagA and VacA, were strongly associated with CAG.
Introduction
Chronic atrophic gastritis (CAG) is an established precursor of intestinal type gastric cancer (1) , which is the second most common cause of cancer-related deaths worldwide (2) . Helicobacter pylori infection has been identified as a major risk factor both for gastric inflammation and carcinogenesis (3) . Most of the persons carrying the infection display a chronic superficial gastritis without clinical symptoms, only a minority of infected individuals develop CAG and gastric cancer (4) . This clinical diversity is assumed to be caused by the interplay of environmental factors, host susceptibility, and differences in the pathogenicity of different H. pylori strains (5-7).
The genome of H. pylori shows extensive genetic variation which contributes immensely to the different levels of pathogenicity observed among distinct clinical isolates (8) . Cytotoxin-associated gene A (CagA) and vacuolating toxin (VacA) have long been established as important virulence factors of H. pylori (9) (10) (11) . Recently, additional factors that might serve as potential predictors for the development of gastric diseases were identified by immunoproteomics studies (12) (13) (14) (15) (16) . However, very few of them have been confirmed epidemiologically in population-based studies (17, 18) .
The aim of this study was to assess the effect of 15 H. pylori immunogenic proteins on the development of CAG in a large population-based study among older adults from Germany.
Materials and Methods

Study Population
The analyses are based on the baseline data of the ESTHER study, a large population-based cohort study conducted among older adults in Germany to investigate new avenues of prevention and early detection of chronic diseases in the elderly. Details of the study design have been described elsewhere (19) . Briefly, 9,953 participants (45% males), ages 50 to 74 years (mean age, 62 years) were recruited between July 2000 and December 2002 by their general practitioners during a general health check-up in Saarland, a state in the southwest of Germany. The study was approved by the ethics committees of the medical faculty of the University of Heidelberg and of the medical board of the state of Saarland. Written informed consent was obtained from each participant. All 534 cases with serologically defined CAG and 1,068 controls ( frequency-matched on sex and 5-year age group) were included in the analyses.
Data Collection
Questionnaires. A standardized questionnaire was completed by every participant, providing information on sociodemographic characteristics, medical history, health status, family history, and lifestyle factors; lifetime history of smoking and alcohol consumption was obtained. Current alcohol consumption was assessed regarding the amount of average alcohol consumption within the past 12 months in consumption volumes typical for southern Germany. Smoking status was classified into three groups (current, former, and never smokers).
Serologic examinations. Serum samples were obtained from all participants and stored at À80jC. Serum concentrations of pepsinogen (PG) I and II were measured by ELISA (Biohit). The presence of CAG was determined by the following definition which has been frequently used in previous studies (20) : PG I <70 ng/mL and PG I/PG II <3. Such defined cases were further subgrouped into severe cases (PG I <20 ng/mL and PG I/PG II <3) and mild and moderate cases (20 ng/mL VPG I <70 ng/mL and PG I/PG II <3). Initially, the status of infection with H. pylori had been assessed by a commercial ELISA for the presence of IgG antibodies against H. pylori in general and specific to CagA [H. pylori screening ELISA and H. pylori p120 (CagA) ELISA, respectively; ravo Diagnostika; refs. 19, 20] . Classification of infection status followed the manufacturer's instructions, and borderline results were treated as negative.
Serostatus of antibodies to 15 H. pylori-specific antigens (listed in Table 1 ) was additionally determined by novel H. pylori multiplex serology. 3 The multiplex method is based on a glutathione S-transferase (GST) capture immunosorbent assay combined with fluorescent-bead technology (21) . H. pylori proteins were fused with an NH 2 -terminal GST domain and a COOHterminal tag peptide derived from the large T antigen of SV40 and expressed in bacteria. Recombinant GST-H. pylori fusion proteins were loaded and affinity-purified on spectrally distinct glutathione-casein-coupled fluorescence-labeled polystyrene beads (SeroMap, Luminex). Sera were diluted 1:50 in a serum preincubation buffer containing 1 mg/mL of casein and 2 mg/mL of total lysate protein from bacteria overexpressing GST-tag without intervening H. pylori sequences to block the binding of antibodies directed against residual bacterial proteins, GST, and the tag peptide. Binding of the GST-H. pylori fusion proteins to various beads was verified with a monoclonal antibody directed against the COOH-terminal tag peptide. The differently labeled beads loaded with different antigens were mixed and incubated in 96-well plates with an equal volume of the serum dilutions. Antibodies bound to the beads via the GST-H. pylori fusion proteins were stained with biotinylated goat anti-human IgA, IgM, IgG (Dianova), and the reporter conjugate R-phycoerythrin-labeled streptavidin. A Luminex 100 analyzer identified the internal bead color and thus the antigen carried by the bead. The quantity of bound antibodies was determined as the median reporter fluorescence intensity (MFI) of at least 100 beads per bead set per serum.
All sera of the study were analyzed on two consecutive assay days with a quality control panel of 179 sera with known reactivity included each day which was used to correct for interday variation. Pearson correlation coefficients for the individual antigens ranged from 0.90 to 0.97 (median, 0.93) for day 2 versus day 1. For each assay day and antigen, seropositivity thresholds were calculated as the mean MFI value of the last negative and the first positive sample to yield identical seroprevalences in the two quality control data sets. Normalization factors were calculated as the ratio of the two means and data were normalized by multiplying with the antigenspecific normalization factors. The determination of the serostatus of the specific antibodies was based on MFI. As none of the MFI levels for the antigens were normally distributed in the study population, cutoff points to classify sera as positive or negative were calculated based on the geometric mean of the MFI for each specific antigen (Table 1) : geometric mean plus 1 SD of MFI levels observed in the H. pylori negative (defined by the commercial screening ELISA) controls (age <65 years). Excluding the oldest age group from the cutoff point calculation was done to minimize potential bias caused by loss of H. pylori colonization in elderly. In addition, other cutoff points defined by geometric mean + 0.5 SD, geometric mean + 1.5 SD, and geometric mean + 2 SD of MFI levels were used alternatively in sensitivity analyses.
Concordance of CagA detection by commercial ELISA [H. pylori p120 (CagA) ELISA; ravo Diagnostika] and multiplex serology was moderate [j = 0.58; 95% confidence intervals (95% CI), 0.55-0.62]. Antibodies to three proteins (CagA, UreA, and VacA) were determined both by Western blot and multiplex serology for 227 reference sera. The agreement was high for CagA (j, 0.77; 95% CI, 0.69-0.85), moderate for UreA (j, 0.54; 95% CI, 0.43-0.66), and poor for VacA (j, 0.15; 95% CI, 0.04-0.26; Supplementary Table S1 ). Analysis of 180 animal sera with defined serostatus of H. typhlonius, H. bilis, and H. hepaticus infection did not indicate any serologic cross-reactivity with antibodies directed against H. pylori proteins analyzed by multiplex serology.
Statistical Analysis
Cases and controls were characterized with respect to sex, age, education, family history of gastric cancer, alcohol consumption, and smoking status. Differences between cases and controls in these variables were assessed with Pearson's m 2 test. The associations between CAG and antibodies against each of the 15 H. pylori proteins (and also for the previously conducted commercial H. pylori screening ELISA) were assessed by means of odds ratios (OR) and 95% CI using unconditional multiple logistic regression. They were adjusted for the matching variables (age and sex) and other risk factors which differed significantly between cases and controls. To minimize potential underestimation of the association between H. pylori infection and CAG due to clearance of the infection, and subsequently, loss of antibodies with increasing severity of disease (19, 22, 23) , analyses were repeated after excluding cases with severe CAG. The analyses for the antibodies to the 15 H. pylori proteins were then repeated within the group of subjects that had previously been classified as H. pylori-positive by the commercial H. pylori screening ELISA. Again, these analyses were conducted after excluding severe cases. These analyses were carried out to evaluate the specific role of the various antigens as virulence factors for the development of CAG. Pearson correlation analyses of logtransformed MFI levels of the 15 antibodies were performed and colinearity among the variables in the multiple regression analyses was checked.
Stepwise backward multiple logistic regression analysis was used to identify those antibodies that were independently associated with CAG (mild and moderate forms). The initial model contained the variables age, sex, education, and alcohol consumption (each included permanently in the model), and the 15 antibodies. The significance level for antibodies to stay in the model was 0.05. A dose-response relationship between the independent predictors and mild and moderate CAG was evaluated using quartiles of MFI levels to categorize the serostatus for each antigen.
In order to investigate the combined effect of such identified independent predictors, the prevalence of mild and moderate CAG was then assessed according to the number of the seropositivities for pertinent antibodies in each sample. The extended Mantel-Haenszel m 2 test was used to evaluate significance of the trend in CAG according to the number of seropositivities. All statistical analyses were carried out using SAS statistical software, release 9.1.
Results
We analyzed the distribution of sociodemographic and lifestyle factors as well as H. pylori infection (according to the commercial screening ELISA) among the 534 cases (303 of them with severe and 231 with mild or moderate CAG) and 1,065 controls (three additional samples had to be excluded from the analyses due to missing data). As shown in Table 2 , significant differences between cases and controls were observed for education (P = 0.04), alcohol consumption (P = 0.01), and H. pylori infection (P < 0.01). Table 3 depicts the prevalences of seropositivity for the 15 H. pylori-specific antibodies (Cad, Cagy, CagM, CagA, catalase, HcpC, HP0231, HP0305, HpaA, HyuA, GroEL, NapA, Omp, UreA, and VacA) that were analyzed by multiplex serology. In subjects with CAG, prevalences ranged from 37.4% (HpaA) to 84.5% (GroEL) and 11 antibodies showed prevalences of >50%. In the controls, prevalences ranged from 24.9% (HpaA) to 56.2% (GroEL), and only three antibodies showed prevalences of >50%. However, the order of observed frequencies among the antibodies was roughly the same in both groups. This was also true when mild and moderate CAG cases were analyzed separately, with prevalence then ranging from 45.0% to 90.9%. The associations between CAG and seropositivity for each of the 15 antibodies (calculated by means of unconditional multiple logistic regression) are shown in terms of ORs and 95% CI. Associations were significant for all 15 antibodies, even with application of Bonferroni correction, with ORs (95% CI) ranging from 1.73 (1.38-2.18) for HyuA to 4.49 (3.38-5.95) for GroEL while controlling for age, sex, education, and alcohol consumption. However, the associations increased substantially when severe cases of CAG were excluded from the analyses. Adjusted ORs then ranged from 1.85 (1.36-2.52) for NapA to 10.03 (6.24-16.14) for VacA. Most of the other antibodies indicated a 2-fold to 5-fold increased risk, and CagA, GroEL, and HcpC showed associations of 7.34 (4.86-11. Tables S2-4) .
Antibody prevalences and their associations with CAG (mild and moderate forms) were also analyzed after restriction of the samples to subjects classified as H. pylori-positive according to commercial screening ELISA (Table 4) . Even within this restricted sample of H. pylori-positive subjects, all but two markers (catalase and NapA) remained significant predictors of CAG risk. The MFI levels of these 15 antibodies were most moderately correlated (Supplementary Table S5 ). However, no major colinearity was observed; in the multiple regression analyses, the largest condition index was 14.45.
Stepwise backward selection identified CagA, VacA, HcpC, and GroEL as independent significant predictors of CAG, with adjusted ORs of 3.52 (2.01-6.10), 3.19 (1.44-7.05), 4.03 (1.53-10.65), and 2.65 (1.06-6.62), respectively. Significant dose-response relationships between antibody levels and mild and moderate CAG were observed for all these four specific antigens (Table 5) .
Furthermore, in combination, these independent antibodies indicate a higher risk of CAG among H. pylori-seropositive subjects (Table 6 ). Compared with samples seropositive for up to two of these antibodies, the presence of all four antibodies resulted in (6.55-50.61 ) for all forms of CAG, and mild and moderate forms of CAG, respectively, with dose-response trends being highly significant (P < 0.0001).
Discussion
In this population-based study among older adults from Germany, the 15 antibodies against H. pylori (listed in Table 1 ) measured by multiplex serology were all shown to be associated significantly with CAG, with ORs of up to 4.5. Exclusion of severe cases of CAG substantially increased the observed associations, with ORs then reaching up to 10.0. The associations remained significant for all but two antibodies when restricting the analyses to subjects that had been classified as H. pylori-positive by a commercial screening ELISA. CagA, VacA, HcpC, and GroEL were identified as independent virulence factors for CAG with adjusted ORs of 3.52 (2.01-6.10), 3.19 (1.44-7.05), 4.03 (1.53-10.65), and 2.65 (1.06-6.62), respectively. In combination, these four virulence factors were associated with an 18-fold risk of CAG.
H. pylori infection is well recognized as a key risk factor for the development of CAG and gastric cancer. However, not all infected subjects develop CAG and only a small proportion will develop more advanced lesions, and finally, adenocarcinoma (24) . Besides host susceptibility and environmental factors, differences in the virulence of different H. pylori strains are supposed to be an important determinant for such diversity (25) . A prominent example is CagA, which was discovered more than 10 years ago and has now been widely accepted as a relevant virulence factor (26) (27) (28) (29) (30) . Similar results have been obtained for VacA, although its importance is still under debate (29, 31, 32) . However, there is much less evidence from epidemiologic studies regarding other potential virulence factors of H. pylori.
To our knowledge, the present study is the first gastric diseaseoriented epidemiologic study simultaneously investigating antibodies to 15 different H. pylori proteins using multiplex serology. Apart from CagA and VacA, the proteins were selected for the following reasons: catalase (33), GroEL (34), NapA (34, 35) , and UreA (36) have been suggested to play a role in colonization in Table 4 . Associations between seropositivity for specific H. pylori antibodies and mild and moderate CAG in subjects classified as H. pylori-positive
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Mild and moderate cases, n (%) Controls, n (%) OR (95% CI) (37, 38) , and UreA (39, 40) have been shown to play immune protective roles in in vitro experiments; Cagy and CagM were found to be essential for translocation of CagA into gastric epithelial cells (41); Omp was identified as a secreted protein and was suggested to contribute to gastric inflammation and epithelial damage (42) ; and HcpC (a surface protein) was suggested to participate in proinflammatory response like other helicobacter cysteine-rich proteins (43, 44) . Eight of these markers have been shown to be associated with gastric diseases (gastric cancer and peptic ulcer) in clinical settings: Cad, CagM, HP0305, HpaA, HyuA, GroEL, NapA, and UreA (14, 16, 45) . However, among these, only catalase and GroEL were investigated in an epidemiologic study (18) , and none of these antibodies have been analyzed with respect to the development of CAG.
In our study, associations of virulence factors with CAG were consistently stronger when the analysis was restricted to cases with mild and moderate forms of CAG, i.e., when patients with severe forms were excluded. This pattern most likely reflects the clearance of H. pylori infection at severe stages of disease followed by gradual loss of the antibodies, which may have led to underestimation of the association of H. pylori infection with both CAG and gastric cancer in the past. Although disease-related clearance of the infection may still attenuate the associations observed with moderate to mild forms of CAG to some extent, the latter are expected to provide a more valid representation of the true effect of infection than the associations seen for all forms of CAG combined. As expected, the various specific H. pylori antibodies were, in part, strongly correlated. Nevertheless, two markers, HcpC and GroEL, were newly identified as independent virulence factors in our analysis besides CagA and VacA. GroEL is a molecular chaperone which is required for the proper folding of many proteins in bacteria (46) . Additionally, it was reported that GroEL may play a role in gastrointestinal homeostasis due to the ability to bind to components of the gastrointestinal mucosa and to aggregate H. pylori (47) . The biological roles of HcpC are not yet clear (43) . HcpA, a closely related member of the Hcp family, was reported to trigger the release of a concerted set of cytokines to instruct the adaptive immune system for the initiation of proinflammatory responses (43, 44) . These findings support a potential role for HcpC in H. pylori pathogenesis, but no previous study has reported on the associations of HcpC with gastric disease. Therefore, further studies are needed to confirm and clarify its roles during the development of gastric diseases. Even though the remaining antibodies did not show a significant independent association with CAG after CagA, VacA, HcpC, and GroEL had been controlled for, their potential use in algorithms to delineate subjects at higher risk of CAG may still require careful attention and evaluation.
In the interpretation of our data, some limitations have to be considered. The definition of CAG based on serum pepsinogen concentrations cannot be claimed to be perfect. However, high levels of agreement with classification by gastroscopy with subsequent histologic examination of biopsies have been observed, even though the latter has been shown to bear considerable observer variation (48) , and to suffer from sampling error (49) . Recently, a high agreement (>95%) between serologic and histologic diagnoses was reported in a European population (50) . Likewise, serologic determination of the H. pylori infection status is imperfect to some extent. Part of the apparent lack of specificity when comparing the results of a screening ELISA to histology and culture reflects the persistence of antibodies for some time after clearance of the infection. However, lifetime infection with H. pylori seems to be much more relevant with respect to the development of CAG than the current status of infection. In fact, the largest threat to the validity of associations with CAG seems to emerge from disease-related clearance of the infection, which we aimed to minimize by excluding cases with most severe forms of CAG.
In conclusion, seropositivity for each of the 15 antibodies against H. pylori measured by novel multiplex serology was associated significantly with CAG in our study population. Associations were much stronger after excluding cases at severe stages of disease. CagA, VacA, HcpC, and GroEL were found to be independent predictors and, in combination, were strongly associated with CAG. Identification of new virulence factors of H. pylori may help to define high-risk groups among the large number of infected people on whom to focus clinical intervention or surveillance. Our finding should be replicated in independent studies and with respect to other disease outcomes, such as gastric cancer, and future research should evaluate still other potential virulence markers to further enhance risk stratification.
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